Viome announces $86.5M round, CVS roll out
Viome Life Sciences, a startup diagnostics company, closed an $86.5 million Series C funding round Friday.
Viome has developed multiple diagnostic tests for gut and oral health, which are meant to inform a user’s diet and lifestyle decisions. After taking the diagnostic test, Viome provides results directly to consumers via its mobile app.
The results are meant to be actionable for users by informing dietary and supplement needs. Based on test results, Viome may recommend personalized supplements or biotics that it sells directly to consumers.
Related: Women's health company Visana raises $10M seed round
Venture firms Khosla Ventures and Bold Capital led the round. The company plans to use the funding to grow and launch new consumer tests and market its professional services business.The round brings the company's total funding to date to $175 million, according to Viome CEO Naveen Jain.
Viome also said it will roll out its gut health intelligence test directly to consumers in around 200 CVS retail stores.
Visana, women’s health clinic, closes $10M seed round
Visana Health, a virtual women’s health clinic, closed a $10.1 million seed funding round co-led by Flare Capital Partners and Frist Cressey Ventures.
The company plans to use the funds to hire additional clinicians and make technology investments in its platform that is licensed in 50 states. Visana has no immediate plans to open brick-and-mortar clinic locations or to market its services directly to consumers, co-founder and CEO Joe Connolly said..
Mendaera gets $24M from Thiel's Founders Fund, others
Mendaera, a medical robotics healthcare technology company, raised a $24 million Series A funding round on Thursday.
The round was led by Lux Capital with support from billionaire Peter Thiel's venture capital firm Founders Fund. Other investors included Intuitive Surgical and former U.S. Sen. Bob Kerrey (D-Neb.), who also served as his state's governor.
Mendaera has developed a platform that combines imaging technology with artificial intelligence and robotics for providers. In a blog on its website, the company said it will use the funding to complete product development and add a production facility in Silicon Valley to support growth. The company is also focused on obtaining regulatory clearance from the Food and Drug Administration.
Spectrum Equity places $156M bet on VBA
Investment firm Spectrum Equity has acquired a majority stake in healthcare benefits software company VBA through a $156 million deal that was announced Tuesday.
Spectrum, which previously invested in publicly traded digital health companies GoodRx and Definitive Healthcare, is making its next big bet on interoperability and data. VBA has developed claims and benefits administration software for health plans and third-party administrators.
